Squarepoint
MXCT icon

Squarepoint’s MaxCyte MXCT Stock Holding History

Squarepoint’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.3K Buy
+14,844
New +$14.8K ﹤0.01% 4312
2025
Q3 		– Sell
-22,999
Closed -$50.1K – 4764
2025
Q2 		$50.1K Sell
22,999
-39,605
-63% -$95.9K ﹤0.01% 4305
2025
Q1 		$171K Buy
62,604
+27,961
+81% +$110K ﹤0.01% 4072
2024
Q4 		$144K Sell
34,643
-109,174
-76% -$413K ﹤0.01% 4585
2024
Q3 		$559K Sell
143,817
-172
-0.1% -$725 ﹤0.01% 3011
2024
Q2 		$564K Sell
143,989
-25,153
-15% -$108K ﹤0.01% 2990
2024
Q1 		$709K Buy
169,142
+57,767
+52% +$271K ﹤0.01% 2826
2023
Q4 		$523K Buy
+111,375
New +$434K ﹤0.01% 2981
2023
Q3 		– Sell
-14,173
Closed -$65.1K – 4081
2023
Q2 		$65.1K Sell
14,173
-7,114
-33% -$32.7K ﹤0.01% 3420
2023
Q1 		$105K Buy
+21,287
New +$105K ﹤0.01% 2965
2022
Q3 		– Sell
-24,000
Closed -$114K – 3267
2022
Q2 		$114K Buy
+24,000
New +$118K ﹤0.01% 2600

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Squarepoint's MXCT Position: Q2 2026 in Review

Squarepoint opened a new position in MaxCyte (MXCT) in Q2 2026: 14,844 shares worth $18.3K. The stake represents ﹤0.01% of the portfolio and ranks #4312 among its holdings. This is a return to the name: Squarepoint previously reported a position in MXCT as recently as Q2 2025.

Squarepoint first reported a position in MXCT in Q2 2022 and has held it in 11 quarters since. The position peaked at $709K in Q1 2024. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Squarepoint held 14,844 shares of MaxCyte worth $18.3K as of Q2 2026.
  • MaxCyte was a new Squarepoint position in Q2 2026.
  • MaxCyte made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #4312 holding.
  • Squarepoint first reported a position in MaxCyte in Q2 2022 and has held it in 11 quarters since.
  • Squarepoint's MaxCyte position peaked at $709K in Q1 2024.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.